Predictors of survival in patients with HER2+ metastatic breast cancer (MBC) treated with trastuzumab.
E. M. Olson
Research Funding - Genentech
J. S. Najita
No relevant relationships to disclose
J. Sohl
No relevant relationships to disclose
A. Arnaout
No relevant relationships to disclose
E. P. Winer
Research Funding - Genentech
N. U. Lin
Research Funding - Genentech